157 related articles for article (PubMed ID: 23299359)
1. Treatment of Gram-positive left-sided infective endocarditis with daptomycin.
Kaya S; Yilmaz G; Kalkan A; Ertunç B; Köksal I
J Infect Chemother; 2013 Aug; 19(4):698-702. PubMed ID: 23299359
[TBL] [Abstract][Full Text] [Related]
2. Daptomycin in the treatment of patients with infective endocarditis: experience from a registry.
Levine DP; Lamp KC
Am J Med; 2007 Oct; 120(10 Suppl 1):S28-33. PubMed ID: 17904948
[TBL] [Abstract][Full Text] [Related]
3. [Daptomycin in left-sided endocarditis: A single center experience].
Açar B; Tezer Tekçe Y; Yayla Ç; Ünal S; Ertem AG; Şentürk B; Özcan Çelebi Ö; Aydoğdu S
Turk Kardiyol Dern Ars; 2017 Jun; 45(4):310-315. PubMed ID: 28595200
[TBL] [Abstract][Full Text] [Related]
4. In vivo acquired daptomycin resistance during treatment of methicillin-resistant Staphylococcus aureus endocarditis.
Dortet L; Anguel N; Fortineau N; Richard C; Nordmann P
Int J Infect Dis; 2013 Nov; 17(11):e1076-7. PubMed ID: 23578850
[TBL] [Abstract][Full Text] [Related]
5. Daptomycin for the treatment of gram-positive bacteremia and infective endocarditis: a retrospective case series of 31 patients.
Segreti JA; Crank CW; Finney MS
Pharmacotherapy; 2006 Mar; 26(3):347-52. PubMed ID: 16503714
[TBL] [Abstract][Full Text] [Related]
6. Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus.
Fowler VG; Boucher HW; Corey GR; Abrutyn E; Karchmer AW; Rupp ME; Levine DP; Chambers HF; Tally FP; Vigliani GA; Cabell CH; Link AS; DeMeyer I; Filler SG; Zervos M; Cook P; Parsonnet J; Bernstein JM; Price CS; Forrest GN; Fätkenheuer G; Gareca M; Rehm SJ; Brodt HR; Tice A; Cosgrove SE;
N Engl J Med; 2006 Aug; 355(7):653-65. PubMed ID: 16914701
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of Daptomycin Exposure and Efficacy and Safety Endpoints To Support Risk-versus-Benefit Considerations.
Bhavnani SM; Ambrose PG; Hammel JP; Rubino CM; Drusano GL
Antimicrob Agents Chemother; 2015 Dec; 60(3):1600-7. PubMed ID: 26711755
[TBL] [Abstract][Full Text] [Related]
8. Eosinophilic pneumonia induced by daptomycin.
Hayes D; Anstead MI; Kuhn RJ
J Infect; 2007 Apr; 54(4):e211-3. PubMed ID: 17207858
[TBL] [Abstract][Full Text] [Related]
9. Daptomycin and rifampin for the treatment of methicillin-resistant Staphylococcus aureus septic pulmonary emboli in the absence of endocarditis.
Gomez EO; Jafary A; Dever LL
Microb Drug Resist; 2010 Sep; 16(3):241-4. PubMed ID: 20617926
[TBL] [Abstract][Full Text] [Related]
10. Methicillin-resistant Staphylococcus aureus prosthetic aortic valve endocarditis with paravalvular abscess treated with daptomycin.
Mohan SS; McDermott BP; Cunha BA
Heart Lung; 2005; 34(1):69-71. PubMed ID: 15647736
[TBL] [Abstract][Full Text] [Related]
11. [The second life of daptomycin: analysis of a successful come-back].
Decousser JW; Doucet Populaire F
Med Mal Infect; 2008 Dec; 38 Spec No 2():1-3. PubMed ID: 19185200
[No Abstract] [Full Text] [Related]
12. High-dose daptomycin for cardiac implantable electronic device-related infective endocarditis.
Durante-Mangoni E; Casillo R; Bernardo M; Caianiello C; Mattucci I; Pinto D; Agrusta F; Caprioli R; Albisinni R; Ragone E; Utili R
Clin Infect Dis; 2012 Feb; 54(3):347-54. PubMed ID: 22100575
[TBL] [Abstract][Full Text] [Related]
13. Development of daptomycin resistance during therapy in a patient with methicillin-resistant Staphylococcus aureus endocarditis: A case report.
Sotillo A; Paño-Pardo JR; López-Quintana B; Gómez-Gil R
Enferm Infecc Microbiol Clin; 2016 Oct; 34(8):534-5. PubMed ID: 26778103
[No Abstract] [Full Text] [Related]
14. Successful treatment of methicillin-resistant Staphylococcus aureus mitral valve endocarditis with sequential linezolid and telavancin monotherapy following daptomycin failure.
Joson J; Grover C; Downer C; Pujar T; Heidari A
J Antimicrob Chemother; 2011 Sep; 66(9):2186-8. PubMed ID: 21653600
[No Abstract] [Full Text] [Related]
15. Daptomycin as successful treatment for a refractory case of prosthetic valve endocarditis because of methicillin-sensitive Staphylococcus aureus.
Cheung LL; Yue CS; Fung K; Chu CM; Keung Tso EY
Heart Lung; 2011; 40(2):172-6. PubMed ID: 20800283
[TBL] [Abstract][Full Text] [Related]
16. Effect of vancomycin minimal inhibitory concentration on the outcome of methicillin-susceptible Staphylococcus aureus endocarditis.
Cervera C; Castañeda X; de la Maria CG; del Rio A; Moreno A; Soy D; Pericas JM; Falces C; Armero Y; Almela M; Ninot S; Pare JC; Mestres CA; Gatell JM; Marco F; Miro JM;
Clin Infect Dis; 2014 Jun; 58(12):1668-75. PubMed ID: 24647021
[TBL] [Abstract][Full Text] [Related]
17. Successful salvage therapy with daptomycin after linezolid and vancomycin failure in a liver transplant recipient with methicillin-resistant Staphylococcus aureus endocarditis.
Vernadakis S; Saner FH; Rath PM; Kaiser GM; Mathe Z; Treckmann J; Paul A
Transpl Infect Dis; 2009 Aug; 11(4):346-8. PubMed ID: 19497075
[TBL] [Abstract][Full Text] [Related]
18. High-dose daptomycin therapy for left-sided infective endocarditis: a prospective study from the international collaboration on endocarditis.
Carugati M; Bayer AS; Miró JM; Park LP; Guimarães AC; Skoutelis A; Fortes CQ; Durante-Mangoni E; Hannan MM; Nacinovich F; Fernández-Hidalgo N; Grossi P; Tan RS; Holland T; Fowler VG; Corey RG; Chu VH;
Antimicrob Agents Chemother; 2013 Dec; 57(12):6213-22. PubMed ID: 24080644
[TBL] [Abstract][Full Text] [Related]
19. Successful Use of High-dose Daptomycin in a Child With Staphylococcus aureus Endocarditis.
Prabhudesai S; Kanjani A; Nambi PS; Gnanasambandam S; Ramachandran B
Pediatr Infect Dis J; 2016 May; 35(5):517-8. PubMed ID: 27074655
[TBL] [Abstract][Full Text] [Related]
20. [Efficacy and safety of daptomycin in the treatment of gram-positive infective endocarditis: a meta-analysis].
Ge Y; Zhou J; Ma XJ
Zhonghua Yi Xue Za Zhi; 2023 Jan; 103(3):205-214. PubMed ID: 36649992
[No Abstract] [Full Text] [Related]
[Next] [New Search]
